Stockscreener 앱 받기
6.65
4.07%
0.26
시간 외 거래:
6.61
-0.04
-0.60%
전일 마감가:
$6.39
열려 있는:
$6.51
하루 거래량:
484.49K
Relative Volume:
0.94
시가총액:
$142.92M
수익:
$675.00K
순이익/손실:
$-33.47M
주가수익비율:
-2.3769
EPS:
-2.7978
순현금흐름:
$-29.88M
1주 성능:
-1.63%
1개월 성능:
-0.89%
6개월 성능:
+77.81%
1년 성능:
+946.26%
1일 변동 폭
$6.48
$6.87
1주일 범위
$6.31
$6.92
52주 변동 폭
$0.45
$8.2457
Unicycive Therapeutics Inc Stock (UNCY) Company Profile
명칭
Unicycive Therapeutics Inc
전화
650-384-0642
주소
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
Compare UNCY vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UNCY
Unicycive Therapeutics Inc
|
6.65 | 137.33M | 675.00K | -33.47M | -29.88M | -2.7978 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-21 | 개시 | Guggenheim | Buy |
| 2024-04-04 | 개시 | Piper Sandler | Overweight |
Unicycive Therapeutics Inc 주식(UNCY)의 최신 뉴스
Unicycive Therapeutics (UNCY) Stock Analysis Report | Financials & Insights - Benzinga Japan
Portfolio Recap: Is Unicycive Therapeutics Inc stock risky to hold nowEarnings Summary Report & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Unicycive Therapeutics (UNCY) to Release Quarterly Earnings on Monday - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Investors to Connect - ACCESS Newswire
Pullback Watch: Is Unicycive Therapeutics Inc a potential multi baggerQuarterly Earnings Report & Risk Managed Trade Strategies - baoquankhu1.vn
Stop Loss: Why is Unicycive Therapeutics Inc stock going down2026 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
If You Invested $1,000 in Unicycive Therapeutics Inc (UNCY) - Stock Titan
Unicycive Therapeutics Company Profile & Introduction - Moomoo
UNCY Technical Analysis & Stock Price Forecast - Intellectia AI
UNCY Stock Price, Quote & Chart | UNICYCIVE THERAPEUTICS INC (NASDAQ:UNCY) - ChartMill
Bronstein, Gewirtz & Grossman, LLC Encourages Unicycive Therapeutics, Inc. (UNCY) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Important Notice to Long-Term Shareholders of ASP Isotopes - GlobeNewswire
Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Unicycive Therapeutics, Inc. (UNCY) And Encourages Stockholders to Reach Out - ACCESS Newswire
Notice to Long-Term Shareholders of ASP Isotopes Inc. - GlobeNewswire
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Stockholders to Connect - ACCESS Newswire
Unicycive Therapeutics (NASDAQ:UNCY) Shares Down 0.4%Here's Why - MarketBeat
Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Important Notice to Long-Term Shareholders of Integer Holdings Corp. (NYSE: ITGR): Molina Healthcare, Inc. (NYSE: MOH); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Important Notice to Long-Term Shareholders of Boston - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Encourages Unicycive Therapeutics, Inc. (UNCY) Investors to Inquire about Securities Investigation - ACCESS Newswire
Unicycive Therapeutics (UNCY) price target decreased by 12.88% to 47.43 - MSN
Aug Setups: Is Unicycive Therapeutics Inc on track to beat earningsTrade Volume Report & Fast Gain Stock Tips - baoquankhu1.vn
Kuehn Law Encourages Investors of Unicycive Therapeutics, Inc. to Contact Law Firm - TMX Newsfile
Unicycive Therapeutics : March 2026 Corporate Presentation - marketscreener.com
Important Notice to Long-Term Shareholders of Corcept - GlobeNewswire
UNCY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Piper Sandler Remains a Buy on Unicycive Therapeutics (UNCY) - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Unicycive Therapeutics, Inc. (UNCY) And Encourages Shareholders to Reach Out - ACCESS Newswire
UNCY Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Can Unicycive's OLC Address Hyperphosphatemia's Unmet Need With Its 3P Advantage? - RTTNews
Unicycive’s Kidney Drug Pipeline Puts A Small Stock On The Clock - Finimize
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Will Unicycive Therapeutics Inc. benefit from current market trendsJuly 2025 Snapshot & Verified Entry Point Signals - mfd.ru
Unicycive Therapeutics (UNCY) Gets a Buy from Westpark Capital - The Globe and Mail
Why is Unicycive Therapeutics Inc. stock going downJuly 2025 Spike Watch & Comprehensive Market Scan Insights - mfd.ru
2026-02-19 | Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:UNCY | Press Release - Stockhouse
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Unicycive Therapeutics (NASDAQ:UNCY) Stock Price Up 2.4%Should You Buy? - MarketBeat
2026-02-17 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Investors to Connect | NDAQ:UNCY | Press Release - Stockhouse
Important Notice to Long-Term Shareholders of Unicycive Therapeutics, Inc. (UNCY): Grabar Law Office Is Investigating Claims on Your Behalf - marketscreener.com
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Will Unicycive Therapeutics Inc. stock go up in YEAR2025 Trade Ideas & Safe Entry Zone Tips - mfd.ru
UNCY Should I Buy - Intellectia AI
2026-02-12 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Unicycive Therapeutics, Inc. (UNCY) And Encourages Stockholders to Reach Out | NDAQ:UNCY | Press Release - Stockhouse
The Hyperphosphatemia Market was valued at approximately USD 4 billion in 2023, according to DelveInsight - Barchart.com
Unicycive Therapeutics: Speculative Biotech Stock Whipsaws Traders As Wall Street Stays Cautious - AD HOC NEWS
Investor Mood: Is Open Lending Corporation stock a top performer YTDWatch List & Technical Buy Zone Confirmations - baoquankhu1.vn
Unicycive Therapeutics Inc (UNCY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):